| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 2145 |
| 1 | DENOSUMAB | 2106 |
| 2 | POLYETHYLENE GLYCOL 3350 | 1379 |
| 3 | SOMATROPIN | 1073 |
| 4 | DARBEPOETIN ALFA | 1052 |
| 5 | ERENUMAB-AOOE | 989 |
| 6 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 822 |
| 7 | MOMETASONE FUROATE | 757 |
| 8 | ALBUTEROL SULFATE | 750 |
| 9 | EPOETIN ALFA | 542 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRASTUZUMAB-ANNS | 257 | 0.1697 |
| 1 | ADALIMUMAB-ATTO | 194 | 0.1205 |
| 2 | INFLIXIMAB-AXXQ | 99 | 0.0853 |
| 3 | BEVACIZUMAB-AWWB | 346 | 0.0737 |
| 4 | PERFLUOROHEXYLOCTANE | 170 | 0.0731 |
| 5 | TALIMOGENE LAHERPAREPVEC | 89 | 0.0560 |
| 6 | EPOETIN ALFA | 542 | 0.0459 |
| 7 | FLUOCINOLONE ACETONIDE | 141 | 0.0374 |
| 8 | ACLIDINIUM BROMIDE | 186 | 0.0291 |
| 9 | MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE | 466 | 0.0287 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 2646 |
| 1 | RANK Ligand Inhibitor [EPC] | 2106 |
| 2 | Corticosteroid [EPC] | 1784 |
| 3 | Osmotic Laxative [EPC] | 1550 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 1052 |
| 5 | Recombinant Human Growth Hormone [EPC] | 925 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 907 |
| 7 | Estrogen [EPC] | 523 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 413 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 411 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Semifluorinated Alkane [EPC] | 170 | 0.0731 |
| 1 | Recombinant Human Growth Hormone [EPC] | 925 | 0.0421 |
| 2 | Gonadotropin [EPC] | 52 | 0.0237 |
| 3 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 36 | 0.0202 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 1052 | 0.0195 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 240 | 0.0158 |
| 6 | RANK Ligand Inhibitor [EPC] | 2106 | 0.0103 |
| 7 | Uric Acid-specific Enzyme [EPC] | 33 | 0.0085 |
| 8 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 202 | 0.0063 |
| 9 | Osmotic Laxative [EPC] | 1550 | 0.0052 |